[HTML][HTML] Epigenetic modifications in acute myeloid leukemia: prognosis, treatment, and heterogeneity
SL Goldman, C Hassan, M Khunte, A Soldatenko… - Frontiers in …, 2019 - frontiersin.org
Leukemia, specifically acute myeloid leukemia (AML), is a common malignancy that can be
differentiated into multiple subtypes based on leukemogenic history and etiology. Although …
differentiated into multiple subtypes based on leukemogenic history and etiology. Although …
The genomics of acute myeloid leukemia in children
SE Conneely, RE Rau - Cancer and Metastasis Reviews, 2020 - Springer
Acute myeloid leukemia (AML) is a clinically, morphologically, and genetically
heterogeneous disorder. Like many malignancies, the genomic landscape of pediatric AML …
heterogeneous disorder. Like many malignancies, the genomic landscape of pediatric AML …
[HTML][HTML] An updated overview of the role of CYP450 during xenobiotic metabolization in regulating the acute myeloid leukemia microenvironment
C Sandoval, Y Calle, K Godoy, J Farías - International Journal of …, 2023 - mdpi.com
Oxidative stress is associated with several acute and chronic disorders, including
hematological malignancies such as acute myeloid leukemia, the most prevalent acute …
hematological malignancies such as acute myeloid leukemia, the most prevalent acute …
Acute myeloid leukemia
B Johansson, CJ Harrison - … Cytogenetics: Chromosomal and …, 2015 - Wiley Online Library
Acute leukemia is a worldwide disease with an incidence of approximately 4/100 000 per
year; 70% of the cases are acute myeloid leukemia (AML). The salient pathologic feature of …
year; 70% of the cases are acute myeloid leukemia (AML). The salient pathologic feature of …
Measurable residual disease testing for personalized treatment of acute myeloid leukemia
M Ehinger, L Pettersson - Apmis, 2019 - Wiley Online Library
This review summarizes–with the practicing hematologist in mind–the methods used to
determine measurable residual disease (MRD) in everyday practice with some future …
determine measurable residual disease (MRD) in everyday practice with some future …
[HTML][HTML] Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study
BR Vundinti, S Korgaonkar, S Dhangar… - Journal of Cancer …, 2023 - journals.lww.com
Aims: The aim of the present study was to study the pattern and frequency of chromosomal
aberrations in acute myeloid leukemia (AML) subgroups from western India. Settings and …
aberrations in acute myeloid leukemia (AML) subgroups from western India. Settings and …
Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4+ UK perspective
M Ruiz, K Jindal, V Casey, LM Soares… - Future …, 2024 - Taylor & Francis
Aim: To explore the incorporation of novel agents in the first-line setting for acute myeloid
leukemia patients. Materials & methods: Observational study based on data from a multi …
leukemia patients. Materials & methods: Observational study based on data from a multi …
Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement
Objectives We sought to characterize the immunophenotype of acute myeloid leukemia
(AML) with CBFB rearrangement and correlate the results with cytogenetic and molecular …
(AML) with CBFB rearrangement and correlate the results with cytogenetic and molecular …
Acute myeloid leukemia with t (16; 16)(p13; q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology
F Albano, L Anelli, A Zagaria, N Coccaro, G Tota… - Human pathology, 2014 - Elsevier
Acute myeloid leukemia (AML) cases with inv (16)(p13q22) or t (16; 16)(p13; q22) are
characterized by multiple CBFB-MYH11 fusion transcripts, type A being the most frequent …
characterized by multiple CBFB-MYH11 fusion transcripts, type A being the most frequent …
Acute myeloid leukemia with inv (16)(p13. 1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts.
Z Mangaru, S Shetty, V Visconte, HD Liu… - American Journal of …, 2016 - europepmc.org
Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of
peripheral blood and bone marrow blasts. - Abstract - Europe PMC Sign in | Create an …
peripheral blood and bone marrow blasts. - Abstract - Europe PMC Sign in | Create an …